COVID-19: Vaccines and Therapeutics

May 24, 2022
The Centers for Disease Control and Prevention today released updated guidance for clinicians treating COVID-19 in patients who received the Pfizer COVID-19 antiviral pill Paxlovid. 
May 23, 2022
Pfizer’s COVID-19 vaccine booster for children under age 5 was 80.3% effective and well tolerated in a clinical trial.
May 20, 2022
The FDA Tuesday authorized a single booster dose for children in this age group. 
May 18, 2022
The U.S. Postal Service has delivered about 350 million free at-home tests to households since January.
May 17, 2022
FDA today authorized a single booster dose for children 5-11 who completed the Pfizer vaccine primary series at least five months before.
May 11, 2022
FDA yesterday approved using baricitinib to treat COVID-19 in certain hospitalized adults, and warned not to use a Skippack Medical Lab test.
May 9, 2022
FDA issues updates on a COVID-19 monoclonal antibody and antiviral pill, and certain Fresenius Medical Care hemodialysis machines.
May 9, 2022
The guidance is intended to help state policymakers identify and address related issues during and after the public health emergency.
May 6, 2022
Based on an updated analysis, FDA said the risk of thrombosis with thrombocytopenia syndrome warrants limiting the vaccine to certain adults.
May 5, 2022
This webinar rural hospital executives and board leaders discuss how boards can work with all levels within their communities.